Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

NCT03516708 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03516708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03516708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Lead sponsor
Washington University School of Medicine
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 6, 2020
Completion date
August 12, 2030
Enrollment
49 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer